Article: Perioperative management of metformin: is there something new?
2020 Volume 159, Issue 6, Page(s) 210–212
Abstract: Metformin is the drug of choice in the treatment of type 2 diabetes mellitus. Diabetic patients treated with metformin, who are scheduled for surgery, have always been subjects to discussion regarding the perioperative management of metformin because of ... ...
Title translation | Perioperační podávání metforminu: co je nového? |
---|---|
Abstract | Metformin is the drug of choice in the treatment of type 2 diabetes mellitus. Diabetic patients treated with metformin, who are scheduled for surgery, have always been subjects to discussion regarding the perioperative management of metformin because of the risk of developing lactic acidosis. The article presents the basic informations about this adverse event, describes new approach to the metformin treatment in the perioperative period, and summarizes the recommendations of professional societies and expert groups. |
MeSH term(s) | Acidosis, Lactic ; Diabetes Mellitus, Type 2/drug therapy ; Humans ; Hypoglycemic Agents/adverse effects ; Metformin/adverse effects ; Perioperative Period |
Chemical Substances | Hypoglycemic Agents ; Metformin (9100L32L2N) |
Language | English |
Publishing date | 2020-12-07 |
Publishing country | Czech Republic |
Document type | Journal Article |
ZDB-ID | 413441-2 |
ISSN | 1805-4420 ; 0008-7335 |
ISSN (online) | 1805-4420 |
ISSN | 0008-7335 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 278: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.